Back
Spyre Therapeutics Stock Predictions
Sponsored
SYRE
Sponsored
Recent Tech Boom Could Send "EarnPhone" Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
SYRE
Spyre Therapeutics
Last Price:
$23.00
Seasonality Move:
0.26%
7 Day Trial
ALL ACCESS PASS
$
7
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Spyre Therapeutics Stock Forecast
-
Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 5.4% based on the past 8 years of stock performance.
-
Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
-
Is Spyre Therapeutics Stock Undervalued?The current Spyre Therapeutics [SYRE] share price is $23.27. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Spyre Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 5.4% based on the past 8 years of stock performance.
Spyre Therapeutics Stock Rating
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics overpriced?
-
Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Spyre Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com
52-Week Data
52-Week High:
47.97
52-Week Low:
20.07
Prediction Charts
Market Cap:
1.4B
Price in USD:
23.27
Volume:
467.8K
Beta:
2.48
Technical Analysis
SMA50:
23.66
SMA100:
27.41
SMA200:
28.69
52-Wk Change:
3.24%
Stock Predictions
-
Is Spyre Therapeutics stock public?Yes, Spyre Therapeutics is a publicly traded company.
-
What is the Spyre Therapeutics stock quote today?The Spyre Therapeutics stock price is 23.27 USD today.
-
How to buy Spyre Therapeutics stock online?You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-24 | 21.85 | 21.60 | 22.44 | 21.00 |
Jan-27 | 21.31 | 20.82 | 22.81 | 20.66 |
Jan-28 | 20.77 | 21.79 | 22.00 | 20.25 |
Jan-29 | 21.66 | 21.90 | 22.18 | 21.35 |
Jan-30 | 22.13 | 22.27 | 22.74 | 21.79 |
Jan-31 | 22.50 | 22.99 | 23.59 | 22.25 |
Feb-3 | 22.04 | 22.90 | 23.68 | 21.67 |
Feb-4 | 22.75 | 23.70 | 23.84 | 22.60 |
Feb-5 | 23.78 | 23.56 | 24.83 | 23.41 |
Feb-6 | 23.54 | 23.86 | 24.35 | 23.42 |
Feb-7 | 23.72 | 22.65 | 24.39 | 22.44 |
Feb-10 | 22.87 | 22.75 | 23.00 | 22.11 |
Feb-11 | 22.35 | 22.15 | 22.75 | 21.90 |
Feb-12 | 21.63 | 23.27 | 23.35 | 21.13 |
Spyre Therapeutics Earnings
Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Spyre Therapeutics Forecast Revenue Growth
Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $1.17 per share.
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.